Skip to content

Fehling Medizintechnik GmbH

GermanyFDA applicant, unverified

Devices
1

What Fehling Medizintechnik GmbH makes

Fehling Medizintechnik GmbH manufactures the Myocard Biopsy Forceps, a device designed for obtaining tissue samples from the heart muscle during cardiac procedures.

The Myocard Biopsy Forceps is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Myocard Biopsy Forcep Ref K881412

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Fehling Medizintechnik GmbH have in the registry?

The registry currently lists 1 device for Fehling Medizintechnik GmbH. Devices recorded under merged duplicate company entries are counted once.

Which registries list Fehling Medizintechnik GmbH's devices?

Among its 1 most recently registered device, Fehling Medizintechnik GmbH has devices listed in FDA 510(k) (1 device).

What risk classes do Fehling Medizintechnik GmbH's devices fall under?

Among its 1 most recently registered device, the classes recorded for Fehling Medizintechnik GmbH's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Fehling Medizintechnik GmbH in the registry?

The most recently registered devices listed for Fehling Medizintechnik GmbH include MYOCARD BIOPSY FORCEP.

Generated automatically from registry data and not verified by a human reviewer.